You are here

  • Home
  • Archive
  • Volume 89, Issue 3
  • A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients

Citation Tools

Article menu
Download PDFPDF
Clinical science
Scientific reports
A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Nakahara M, Miyata K, Otani S, et al
A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients
British Journal of Ophthalmology 2005;89:266-268.